Download presentation
Presentation is loading. Please wait.
Published byLynn Robertson Modified over 8 years ago
5
179 monozigoturi da 85 dizigoturi wyvili iqna gamokvleuli F filtvebis disfunqciasa da sisxlZarRvebis elastiurobis daqveiTebas Soris inaxa mWidro genetikuri urTierTkavSiri aTerosklerozsa da sasunTqi gzebis daavadebebs aqvT genetikuri korelacia.
7
TST- is aqvs axal testebze meti an toli sensitiuroba T-SPOT -is gamoyenebisas meti pozitiuri Sedegi iqna miRebuli, vidre Quantiferon-TB GOLD- s dros specifiuroba orive axali testisa gacilebiT maRalia, vidre TST- is specifiuroba Quantiferon-TB GOLD- isa T-SPOT-TB -is BCG- vaqcinirebul pirebSi erTnairia Sualeduri(ganusazRvreli) Sedegebi erTnairia CD4+-is donem ar moaxdina raime gavlena testebis Sedegze (461,29±307,49 )( I. Latorre, X. Martinez-Lacasa, R. Font, A. Lacoma, J. Puig, C. Tural, E. Cuchi, J. Lite, C. Prat, M. Perez, V. Ausina, J. Dominguez (Terrassa, Badalona, Spain ) CD4 + and CD8 + T -ujredebisadmi PPD- s pecifiuroba mcirdeba dabali incidentobis qveynebSi, SedarebiT maRali incidentobis qveynebisa (20% vs 64,1%) (C. Giehl (Saarbrucken, Germany))
8
upiratesoba mieniWos mantus tests (TST ) maRali incidentobis qveynebSi IFG-assay aqtiurad gamoiyenos latenturi DA tuberkulozis diagnostirebisTvis dabali incidentobis qveynebSi
9
gama-interferonis producirebuli proteini ( Interferon gamma-induced protein 10 kDa (IP-10). miekuTvneba CXC jgufis citokinebs sekretirdeba IFN-γ sapasuxod monocitebis, endoTeliaruli ujredebisa da fibroblastebis mier IFN-γ misi done momatebulia virusuli “C” hepatitis dros IP-10- is donis 150 pg/mL- ze nakleboba aiv-inficirebul pirebSi arT-Terapiis dawyebamde iTvleba keTilsaimedo niSnad Kkvlevebma aCvenes, rom IP-10 aseve avlens specifiur pasuxs tuberkulozuri mikobaqteriis mimarT A aiv-inficirebul pirebSi IP-10 iyo markeri M. tuberculosis –is sapasuxod, damoukideblad CD4+T ujredebis donisa ( D. Goletti, A. Raja, B. Syed Ahamed Kabeer, C. Rodrigues, A. Sodha, O. Butera, S. Carrara, G. Vernet, C. Longuet, S. Tangara, M. Leportier, E. Girardi, P. Lagrange (Roma, Italy; Chennai, Mumbai, India; Lyon, Marcy L'Etoile, Paris, France)
10
dafuZnebulia ESAT6/CFP10),
12
Seqmnilia seCenovis sax. moskovis samedicino akademiis molekuluri medicinis samecniero-kvleviT institutSi gavlili aqvs aprobacia moskovis, sanqt-peterburgis, samaris da riazanis tub. dawesebulebebSi
13
axasiaTebs usafrTxoebis maRali profili maRali specifiuroba 90-100% (p<0,05) maRali mgrZnobeloba 98-100% (p<0,05) hiperergiuli reaqcia (vezikulut-nekrotuli forma, limfangiti, limfangoiti) - 2-14% (p<0,05) mniSvnelovani imunosupresiis dros testi SeiZleba iyos uaryofiTi saSualebas iZleva vimsjeloT procesis aqtivobaze da SevafasoT antituberkulozuri Terepiis efeqturoba (gankurnebulebSi testi uaryofiTia)
14
gacilebiT iafia ar saWiroebs maRalteqnologiebs (ELISA, T- SPOT) ar saWiroebs maRalkvalificiur laboratoriul personals
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.